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Abstract
Kyphoscoliosis (KS) is a significant clinical problem with no precise guidelines for management, especially concerning respiratory 
pathology. No exhaustive systematic review has yet been performed. The aim was to conduct a systematic review of available 
data concerning the pathophysiology and treatment of kyphoscoliosis.
An electronic systematic search compliant with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines was conducted. The Pubmed database was examined and the search was updated to November 10, 2016. In total, 
188 articles were screened, and 52 full text articles were then assessed for eligibility. As 24 of them met exclusion criteria, only 
28 articles were further analysed. These articles were published in 18 journals from 1959 to 2015, with 25 being original studies, 
and one randomised control trial. The total corpus included 18 prospective studies, 7 retrospective studies and 3 case reports.
 KS is a significant complex, multidisciplinary clinical problem. The heterogeneous nature of the majority of published studies 
prevents unequivocal conclusions being drawn. Despite a great progress in knowledge about the respiratory system functioning 
and pathology in KS, the treatment seems to be not yet quite satisfactory. Therefore, there is a strong need for large prospective 
studies and unified clinical guidelines on the management of this group of patients.
Key words: kyphoscoliosis, respiratory failure, non-invasive ventilation, NIV, treatment
Adv. Respir. Med. 2017; 85: 352–357
Introduction
Kyphoscoliosis (KS) is an excessive curvature 
of the spine in the coronal and sagittal plane cau-
sed by vertebral anomalies [1]. It affects about 1% 
of the population but only 10% of the cases pre-
sent significant clinical symptoms. Most KS cases 
are mild and have no impact on everyday life of 
the patient [2]. The deformity is probably known 
from antiquity — the first description of kyphosco-
liosis probably dates from about 400 BC, as given 
by Hippocrates [2]. Moreover, KS is believed to 
be present in ancient Egyptian mummies, basing 
on an analysis of King Tutankhamun’s family [3].
The aetiology of KS remains uncertain. It may 
eventuate due to traumatic injury in childhood, 
tuberculosis of the spine, or post-rachitic or neu-
romuscular kyphoscoliosis due to poliomyelitis 
in infancy; however, the most common form is 
idiopathic kyphoscoliosis [4, 5]. 
Patients with KS have a characteristic body 
appearance characterised by a short stature due 
to reduction of the rib cage and trunk, and the 
presence of a hump created by the deformed tho-
racic cavity. However, the head, neck and limbs 
are normal in their length. The severity of KS is 
judged by the Cobb angle, which can be estimated 
by the angle formed by the intersection of two 
lines: a perpendicular to a line drawn across the 
superior endplate of the upper-end vertebra, and 
the inferior endplate of the lower-end vertebra of 
the deformity [5]. The most extreme deformities 
have been observed due to tuberculosis KS and 
polio KS [2]. The patients demonstrate a greater 
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Figure 1. Flow chart of papers selection for inclusion to the study [8]
risk of muscle fatigue associated with ageing, and 
their chest wall compliance decreases [1]. These 
changes lead to impairment of the respiratory 
system and cause hypoventilation, hypercapnia 
and pulmonary hypertension, finally resulting 
in chronic respiratory failure (CRF) [6, 7]. These 
foregoing conditions affect the deterioration of 
health-related quality of life (HRQL). HRQL is 
an important clinical indicator, which should 
be taken into account while choosing therapy 
in patients with chronic problems [6]. There are 
no strict indications for surgical intervention; 
however, it should be performed in an early 
phase of the illness to prevent the exacerbation 
of deformation and development of severe lung 
disorders [1].
Kyphoscoliosis is a significant clinical prob-
lem and there are no precise guidelines for 
management, especially concerning respiratory 
pathology. Therefore, the aim of our study was 
to perform a systematic review summarising the 
present state of knowledge in the field.
Material and methods
The search included records dated before 
November 10, 2016 in the Pubmed database. The 
search term employed was “kyphoscoliosis and 
respiratory failure”; yielding 190 results being 
obtained. From these articles, 180 were chosen 
that were connected with the subject of study: 
A total of 136 articles related to orthopaedics, 
paediatrics, neurology, surgery and genetics were 
excluded. Of the 52 remaining studies, 24 were 
based on mixed groups, making difficult to draw 
unequivocal conclusions about patients with 
kyphoscoliosis (Fig. 1) [8], and the remaining 28 
were passed to the next stage of analysis. In ad-
dition, another eight articles from the references 
were added. All reviewed articles were published 
in the period from 1959 to 2015 and came from 
18 various journals. Twenty-five of them were 
original studies, with one randomised control 
trial. The corpus included 18 prospective studies, 
7 retrospective studies and 3 case reports (Fig. 1).
Lung function and mechanics  
of the respiratory system
KS, as a deformity of the thoracic wall, may 
influence mechanics of the respiratory system and 
lung function. Bergofsky et al. [2] have report-
ed three main anatomical changes in the lung: 
chronic pulmonary emphysema with bronchial 
obstruction, changes in the small vessels of the 
lung and tangled and compressed vessels. Due 
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to these changes, patients report the presence 
of coughing, sputum and wheezing, which can 
indicate asthma or bronchitis [2].
Increased residual volume (RV) to total lung 
capacity (TLC) ratio was also reported in cases of 
KS; this can be caused by a significant reduction 
in TLC and slight reduction in RV. Therefore, 
the nature of the above mentioned pathology is 
different from that observed in emphysema or 
chronic obstructive pulmonary disease, in which 
RV is found to be higher than normal [2].
Conti et al. [5] have reported on a reduction 
in the respiratory system compliance (CRS) by 
about 30%, and a  substantial increase in the 
ohmic and viscoelastic resistance component of 
the respiratory system in patients with KS com-
pared with a control group. An increase in total 
resistance in the respiratory system results mainly 
from increased tissue resistance and marginally 
from a reduction in the airway size. The airway 
resistance did not respond to administration of 
doxophylline at a dose of 6 mg/kg, which suggests 
that it has been induced by irreversible factors, 
such as airway deformity and retention of fluids. 
The authors have noted no correlation between 
compliance and resistance values and the amount 
of inspired oxygen [5].
There is also evidence that patients with KS 
have weakened functioning of the respiratory 
muscles, which may be confirmed by the mea-
surement of transdiaphragmatic pressure during 
normal breathing and during maximal inspira-
tion [7]. A correlation has been found between 
this pressure and abnormalities in gas exchange 
[5, 9]. Reduction in TLC and vital capacity (VC) 
can be observed during the progression of the 
disease; these are caused by a gradual decline 
in respiratory system compliance, modification 
of the position of the chest wall and mechanical 
impairment of the respiratory muscles [10].
It is worth emphasising that McMaster et al. 
have found no statistically significant correla-
tion between the size of the Cobb angle and the 
impairment of the lung function [1]. Similarly, 
Conti et al. have reported no connection between 
the Cobb angle and vital capacity values and 
mechanics variables [5]. However, when scoli-
osis and kyphosis were considered separately, 
a correlation was found between the Cobb angle 
of kyphosis and the failure of the respiration [1]. 
A major impairment of lung function is often 
observed when the kyphotic parts of the defor-
mity predominate, probably caused by forward 
angulation of the spine and compression of the 
ribs on both sides, thus impairing the movements 
of the diaphragm [1]. Tests based on forced vital 
capacity (FVC) and forced expiratory volume in 
one second (FEV1) have found the height of the 
apex of the kyphotic part of the kyphoscoliosis 
to be negatively associated with the results of 
the respiratory function tests, i.e. a higher apex 
is related to a poorer result [1].
Exercise training and respiratory rehabilitation
Many patients with kyphoscoliosis exhibit 
exercise limitation even though they demonstrate 
a normal breathing response to physical effort. 
Studies have shown that intolerance of exercise 
may arise from physical impairment [11]. The 
six-minute walking test (6MWT) is a simple way 
to assess endurance and exercise limits. The most 
important factor that affects the outcome of the 
6MWT is dyspnoea at the beginning of the test. The 
Borg scale for dyspnoea is significantly negatively 
correlated with the outcomes. In spirometry, only 
FEV1 has been found to correlate with six-minute 
walking distance (6MWD), and this relationship 
is weak negative. Body mass index (BMI) and 
age have been negatively correlated with 6MWD, 
but no correlation has been found with the lev-
el of arterial blood gases. Karakurt et al. [12] 
have reported that patients with kyphoscoliosis 
walked a much shorter distance than they ought 
to (median 270 m — 43.7% of predicted distance) 
[12]. Oxygen supplementation at the beginning 
and during the 6MWT did not elongate 6MWD, 
but long-term therapy with non-invasive ven-
tilation (NIV) was found to have a  significant 
positive effect [4]. Also, no correlation was found 
between 6MWD and initial desaturation, or be-
tween 6MWD and the size of Cobb angle. There 
is evidence that supplementation of oxygen can 
only improve the score of Visual Analogue Scale 
(VAS) for breathlessness and recovery time after 
exertion, but not the results of 6MWT [10].
A randomised control trial by Cejudo et al. [13] 
examined the influence of exercise on endurance 
and strength. A group of 34 KS patients receiving 
night time home mechanical ventilation (NHMV) 
were divided randomly into two equally-sized 
groups: an exercise group and a control group. 
Pulmonary function, exercise capacity, peripheral 
muscle strength, dyspnoea and HRQL were mea-
sured. The exercise group subjects trained three 
non-consecutive days per week for 12 weeks. The 
training session was supervised and consisted of 
a 10-minute warm-up, 30 minutes of leg exercises 
on an ergometer cycle and 20 minutes of upper 
and lower body strength exercises. The authors 
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reported significant decrease in PaCO2, while 
maximum inspiratory and expiratory pressures, 
as well as endurance time and shuttle walk dis-
tance increased significantly. The exercise group 
had also significantly greater improvements in 
peripheral muscle strength, dyspnoea, and quality 
of life [13].
Cejudo et al. [13] have recommended this 
kind of exercise programme for the treatment of 
chronic respiratory failure due to kyphoscoliosis 
in patients receiving NHMV.
In contrast, Fuschillo et al. [14] have found 
that the combination of pulmonary rehabilitation 
with non-invasive ventilation and long-term oxy-
gen therapy improved peripheral muscle strength, 
HRQL and endurance only for a short period of 
time after the rehabilitation programme. They 
have reported that rehabilitation after a one-year 
follow-up did not prevent the test results decre-
asing. There is clearly a need to determine how 
to best optimise training to increase and maintain 
these benefits for a longer time.
It has also been revealed that the use of NIV 
during exercise decreases effort and fatigue. Pa-
tients who did not use ventilation experienced 
more significant acidosis, hypoxia, hypercapnia 
and dyspnoea [15].
Cardiovascular system
The deformation may significantly influen-
ce cardiovascular system dysfunction as well. 
Bergofsky et al. [2] have observed a positive cor-
relation between age, severity of the deformity 
and the occurrence of cardiological diseases, 
especially in patients aged over 40 and with the 
Cobb angle greater than 100 degrees.
Cardiovascular problems are caused by chan-
ges in the respiratory system. The presence of an 
imbalance between perfusion and diffusion of the 
lung due to deformity of the rib cage and decrease 
in the total lung capacity leads to hypoxaemia. It 
causes hypertrophy and hyperplasia of the medial 
layer of the pre-capillary vessels, causing pulmo-
nary hypertension, with the resulting hypertro-
phy of the right side of the heart being observed 
in most autopsies of KS patients. The second most 
common cause of cardiac failure comprises the 
kinking and compression of the great vessels as 
a result of the rib cage deformity [2].
Pregnancy and delivery
Although this review is focused on the re-
spiratory system, some issues about pregnancy 
and delivery should be mentioned as being cli-
nically significant for the topic. Kyphoscoliosis 
is an uncommon deformation in pregnancy; it is 
estimated that only 0.02% to 0.7% of pregnant 
women suffer from this condition [16, 17]. Ho-
wever, patients experience several complications 
due to the abnormal curvature of the spine, the-
se being classed as either medical or obstetric 
complications. The former consist of pulmonary 
restriction, acute respiratory failure (ARF) and 
CRF, cor pulmonale and heart failure. As the 
greatest risk of pulmonary function deterioration 
usually occurs in the third trimester, monitoring 
of arterial blood gases and overnight oxymetry 
should be performed to identify when ventilation 
support should be commenced [18]. Berman et al. 
[19] have indicated that pregnancy exacerbates 
scoliosis due to mechanical stress and pregnancy 
hormones; hence, Wong et al. [16] have suggested 
reassessment of the spinal curvature after deli-
very. Obstetric complications include gestation 
hypertension, preeclampsia, preterm delivery 
and a higher risk of C-section [15, 16]. Chopra et 
al. [17] have noticed that all delivered babies had 
good Apgar scores and any of the babies had con-
genital malformations. Few complications have 
been recorded during delivery, such as breech 
presentation [17] and deep transverse arrest [20]. 
In such cases, it is recommended that C-section 
is performed under general anaesthesia as the 
changes in spinal curvature and epidural space 
complicate correct needle placement [21].
Treatment of acute respiratory failure 
Infections of the airways can lead to dan-
gerous destabilisation of the respiratory tract 
homeostasis, especially in patients with KS. It 
increases the risk of ARF and the necessity of 
hospitalisation. Banfi et al. [22] have showed that 
KS patients with infection-related ARF can be 
treated successfully and safely at home. In their 
study, seven patients with ARF were treated with 
home mechanical ventilation (HMV) increased 
to 20 hours/day and proper antibiotics. The pa-
tients progressively decreased the daily time of 
mechanical ventilation according to their ability 
to breathe comfortably. After four weeks they 
achieved the same weekly duration of mechani-
cal ventilatory assistance as observed before the 
ARF episode; however, it is important to note that 
HMV can only act as a support treatment for an 
antibiotics regimen [22].
The most common reason for admission to 
intensive care unit (ICU) due to ARF in patient 
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with KS was the occurrence of cor pulmonale 
and sepsis. Sepsis was typically associated with 
pneumonia, but was on rare occasions caused 
by other infections like lower respiratory tract 
infections and urinary tract infections: these 
conditions being indications for treatment in the 
ICU [4] Several studies have compared the use of 
NIV and invasive mechanical ventilation (IMV) in 
KS patients with ARF. The choice of ventilation 
support method depends on the condition of the 
patient during admission to the ICU. Lower pH 
values at admission, occurrence of sepsis, com-
pulsion of using IMV and failure of NIV usage are 
indicators of worse prognosis for ARF patients.
The first to describe the influence of ventila-
tion on the condition of patients during ARF was 
the study performed in 1995 by Finlay et al. [23], 
who identified improved blood oxygen concen-
tration (PaO2) and reduced blood carbon dioxide 
concentration (PaCO2) after nasal intermittent 
positive pressure ventilation. NIV also ameliorat-
ed FEV1 and FVC, as well as FEV1 after discharge 
from hospital. Indicators for NIV failure include 
lower pH and lower PaO2/FiO2 ratio after one hour 
of NIV usage [4]. Patients with successful treat-
ment with NIV and those who are initially intubat-
ed are much less likely to develop sepsis or to die 
than patients with NIV failure. Adigüzel et al. [4] 
strongly discourage the use of NIV in the case of 
sepsis and septic shock.
Treatment of chronic respiratory failure  
and sleep disorders
NIV is now regarded as an option of treating 
CRF in patients with KS [4]. Gustafson et al. [24] 
also have reported that the survival rate of pa-
tients using home mechanical ventilation was 
three times higher than that of patients using 
long-term oxygen therapy alone (LTOT). Pa-
tients with KS are more exposed to hypoventi-
lation during sleep. It can lead to hypoxaemia 
and hypercapnia, which can cause pulmonary 
hypertension and can weaken muscle strength. 
Sawicka et al. [25] have noted that the length 
of the each phase of sleep is correct, but longer 
periods of sleep are associated with greater de-
saturation, especially during rapid eye movement 
(REM) sleep. Desaturations were mainly caused 
by earlier episodes of hypopnea, and to a lesser 
degree, by changes in the chest movements that 
did not meet the criteria of hypopnea resulting 
from dysfunction of the diaphragm [25]. REM 
sleep is characterised by the greatest end tidal 
carbon dioxide tension, which is reflected in 
a greater frequency of hypopnea. Although no 
correlations have been found between desatu-
ration and the Cobb angle size, a  relationship 
has been seen between desaturation, patient 
age and basal vital capacity. It is not possible 
to relate this knowledge to all patients with KS 
because most have comorbidities, which can 
affect breathing during sleep. The most com-
mon conditions that can deteriorate breathing 
problems during sleep are obesity and systemic 
hypertension, as well as associated obstructive 
sleep apnoea. The ideal weight for height in 
patients with KS is difficult to determine. On 
the basis of true height, ideal weight would tend 
to be underestimated [25].
The choice of treatment depends on the 
comorbidities and underlying condition. If the 
patient has obstructive disorders, continuous 
positive airways pressure (CPAP) is recommend-
ed; however, this may not be sufficient in other 
kinds of respiratory pathology. Then, NIV is 
recommended. After three months of NIV in 
KS patients, Ellis et al. [26] have found that the 
length and quality of REM sleep improved, while 
oxygenation increased and transcutaneous carbon 
dioxide tension decreased. After NIV, daytime arte-
rial blood gas results improvement and hospitalisa-
tion rate decrease were observed as well [26, 27]. 
However, NIV does not improve spirometry pa-
rameters [27]. After termination of NIV for a few 
nights, patients again complained about sleepi-
ness, breathlessness during sleep due to the results 
of the tests, which were inappropriate. Buyse et 
al. [28] have identified a higher life expectancy in 
patients with CRF treated with combined LTOT 
with nocturnal nasal intermittent positive pressure 
ventilation (nNIPPV) than those treated with LTOT 
alone: ABG results and vital capacity were both 
improved [28, 29]. Other studies have shown that 
nNIPPV improves PaO2 and PaO2/FiO2 ratio, as well 
as FVC and respiratory muscle strength [7]. The 
use of this type of ventilation support decreased 
the frequency of hospitalisation: no admissions to 
the pulmonology ward were required due to respi-
ratory failure during the course of therapy. Effects 
were observed after six months of therapy [7].
Health-related quality of life
Patients with KS complain about chronic 
fatigue, dyspnoea, aggravating functional status 
and frequent readmission to hospital, all of which 
decrease the quality of life. Cejudo et al. [6] have 
found that tiredness had the most significant 
impact on HRQL, followed by peripheral muscle 
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strength, dyspnoea and exercise capacity. They 
recommend the use of home mechanical ventila-
tion and a suitable training programme.
Summary
KS is a significant complex, multidisciplina-
ry clinical problem. The results of the majority 
of published studies are heterogeneous, which 
currently prevents unequivocal conclusions 
from being drawn. Coming back to the question 
asked in the title: what can we do for respiration 
besides NIV? The answer is: little. Although the 
deformity is probably known from antiquity, and 
despite a great progress in knowledge about the 
respiratory system functioning and pathology in 
KS, the treatment seems to be not yet quite satis-
factory. Therefore, there is a strong need for large 
control trials and unified clinical guidelines on 
the management of this group of patients.
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